The alpha1-adrenergic receptors in cardiac hypertrophy: signaling mechanisms and functional implications

Susanna Cotecchia1, Cosmo Damiano Del Vescovo2, Matilde Colella1

  • 1Dipartimento di Bioscienze, Biotecnologie e Biofarmaceutica, Università di Bari, Via Orabona 4, 70125 Bari, Italy.

Cellular Signalling
|July 15, 2015
PubMed

Insights

Alpha1-adrenergic receptors (α1-ARs) are key drivers of cardiac hypertrophy, a heart remodeling process. This review summarizes α1-AR signaling pathways and their role in heart failure development.

Area of Science:

  • Cardiology
  • Molecular Biology
  • Pharmacology

Background:

  • Cardiac hypertrophy involves cardiomyocyte growth and increased heart mass, potentially leading to heart failure.
  • Prolonged cardiac hypertrophy is a major cause of human morbidity and mortality.
  • Alpha1-adrenergic receptors (α1-ARs) are implicated in cardiac hypertrophy development.

Purpose of the Study:

  • To review the signaling pathways activated by α1-ARs in the heart.
  • To discuss the functional implications of these pathways in cardiac hypertrophy.
  • To highlight recent findings and emerging hypotheses on α1-AR roles.

Main Methods:

  • Review of existing literature on α1-AR signaling in cardiac hypertrophy.
  • Analysis of studies using primary cardiomyocyte cultures.
  • Examination of data from genetically modified mouse models.

Main Results:

  • α1-ARs activate diverse signaling cascades contributing to cardiac hypertrophy.
  • Specific signaling events mediate the molecular and cellular changes in hypertrophied hearts.
  • Novel signaling mechanisms and functional roles of α1-ARs are continually being identified.

Conclusions:

  • Understanding α1-AR signaling is crucial for addressing cardiac hypertrophy.
  • Targeting α1-AR pathways may offer therapeutic strategies for heart failure.
  • Ongoing research continues to refine our knowledge of α1-AR involvement in cardiac remodeling.

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.4K
Adrenergic Receptors (Adrenoceptors): Classification01:27

Adrenergic Receptors (Adrenoceptors): Classification

Adrenergic receptors, or adrenoceptors, respond to the autonomic neurotransmitter noradrenaline and other endogenous catecholamine agonists. They are classified into two main families, α and β, based on their pharmacological response and are further subdivided depending on their location, elicited response, and affinity to specific agonists or antagonists.
α-Adrenoceptors
α-Adrenoceptors are classified into two main subtypes: α1 and α2. The α1 adrenoceptors,...
5.7K
Sympathetic Signaling01:31

Sympathetic Signaling

Sympathetic signaling, a vital part of the autonomic nervous system, plays a crucial role in mobilizing the body's resources in response to stress or emergencies. It involves the transmission of nerve impulses from sympathetic preganglionic fibers to postganglionic fibers. This results in the release of specific neurotransmitters and activation of adrenergic receptors.
Sympathetic preganglionic fibers release the neurotransmitter acetylcholine (ACh) onto the ganglionic neurons in the...
3.5K
Adrenergic Receptors: ɑ Subtype01:31

Adrenergic Receptors: ɑ Subtype

Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
3.3K
Adrenergic Receptors: β Subtype01:26

Adrenergic Receptors: β Subtype

β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
4.5K
Antihypertensive Drugs: Action of β1 Blockers01:17

Antihypertensive Drugs: Action of β1 Blockers

β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this,...
2.3K